insights_auto
Why is GRAL up 8.07%?
Dive Deeperchevron_right
GRAL:NASDAQ
Grail Inc
$143.26
arrow_upward
+8.07%(+10.70) 1D
$143.43
arrow_upward
+0.12% (+0.17)bedtimeAfter hours
Closed: Oct 2, 4:00:01 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GRAL...
Open
$135.52
High
$143.50
Low
$134.45
Mkt. cap
6.40B
Avg. vol.
1.16M
Volume
875.34K
52-wk high
$151.46
52-wk low
$41.50
EPS
-$9.75
Shares outstanding
44.67M
No. of employees
910
Open
$135.52
High
$143.50
Low
$134.45
Mkt. cap
6.40B
Avg. vol.
1.16M
Volume
875.34K
52-wk high
$151.46
52-wk low
$41.50
EPS
-$9.75
Shares outstanding
44.67M
No. of employees
910
News stories
From web sources and news partners
Simply Wall Street
·
21 hours ago
Why GRAIL (GRAL) Is Up 8.1% And What's Next After Galleri FDA Backing
Profile
GRAIL, Inc. is an American biotechnology company based in Menlo Park, California founded in 2015 seeking to develop an early cancer screening test for people who do not have symptoms. As a startup it was a subsidiary of Illumina, which bought it outright in 2021.
In June 2021, GRAIL launched their liquid biopsy, or multi-cancer early detection test, which they called Galleri test. In 2023, EU regulators ordered Grail to be spun-out from Illumina which was completed on June 24, 2024. Wikipedia
About Grail Inc
CEO-
Employees910
Founded2015
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegrail.com